UPDATE 1-Visa sells additional $1.8 billion of IPO shares
The sale of the over-allotment shares, totaling $1.8 billion, will boost gross proceeds from the IPO to $19.7 billion. On a net basis, excluding fees and commissions, Visa and its bank owners raise...
 

More

  • CHOCOLATE CANDY CREATIONS, INC. (form S-1)

    CHOCOLATE CANDY CREATIONS, INC. Files SEC form S-1, Securities Registration Statement

  • Rexahn Pharmaceuticals Receives AMEX Listing Approval (Business Wire)

    ROCKVILLE, Md.----Rexahn Pharmaceuticals, Inc. , a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, announced today that its common shares have been approved for listing on the American Stock Exchange and are expected to commence trading at the opening of the market on Tuesday, May 27, 2008.